Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. Co. has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder (ADHD). We show 1 historical shares outstanding datapoints in our AIFF shares outstanding history coverage, used to compute AIFF market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AIFF market cap history over the course of time is important for investors
interested in comparing AIFF's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AIFF versus a peer is one thing; comparing
AIFF market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AIFF can fluctuate over the course of history.
With this page we aim to empower investors researching AIFF by allowing them to research the AIFF market cap history. |
Free AIFF Email Alerts:
Video: The Importance of Market Cap
